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ABSTRACT The sliding speed of unregulated thin ﬁlaments in motility assays is only about half that of the unloaded
shortening velocity of muscle ﬁbers. The addition of regulatory proteins, troponin and tropomyosin, is known to increase the
sliding speed of thin ﬁlaments in the in vitro motility assay. To learn if this effect is related to the rate of MgADP dissociation from
the acto-S1 cross-bridge head, the effects of regulatory proteins on nucleotide binding and release in motility assays were
measured in the presence and absence of regulatory proteins. The apparent afﬁnity of acto-heavy meromyosin (acto-HMM) for
MgATP was reduced by the presence of regulatory proteins. Similarly, the regulatory proteins increase the concentration of
MgADP required to inhibit sliding. These results suggest that regulatory proteins either accelerate the rate of MgADP release
from acto-HMM-MgADP or slow its binding to acto-HMM. The reduction of temperature also altered the relationship between
thin ﬁlament sliding speed and the regulatory proteins. At lower temperatures, the regulatory proteins lost their ability to increase
thin ﬁlament sliding speed above that of unregulated thin ﬁlaments. It is hypothesized that structural changes in the actin portion
of the acto-myosin interface are induced by regulatory protein binding to actin.
INTRODUCTION
The role of the regulatory proteins tropomyosin (Tm) and
troponin (Tn) in muscle contraction has been viewed as
controlling only the access of the cross-bridge (control of the
rate of strong cross-bridge binding) to the thin ﬁlament
(Huxley, 1972). This ‘‘steric blocking’’ mechanism is
supported by the following facts: 1), The position of Tm/
Tn on the thin ﬁlament limits subfragment 1 (S1) access to
strong binding sites on actin (Xu et al., 1999). 2), The
isometric force is proportional to the thick and thin ﬁlament
overlap (Edman, 1979; Gordon et al., 1966a,b) and a mono-
tonic function of the calcium bound to the thin ﬁlaments
(Moss, 1992). 3), The unloaded shortening velocity, Vu, in
intact muscle is independent of sarcomere length from 1.7–
3.1 mm (Gordon et al., 1966b). These results support A. F.
Huxley’s cross-bridge model that predicts that Vu is
independent of the number of cross-bridges attached to the
thin ﬁlament but is limited by a drag imposed by strongly
bound cross-bridges (Huxley, 1957). The fact that regulatory
proteins exert little or no effect on the acto-myosin S1
ATPase Vmax in solution, when Ca
21 is bound to troponin,
also supports this view (Williams et al., 1988; Tobacman
et al., 2002).
However, other data suggest that regulatory proteins can
modulate the size of the power stroke, the duration of cross-
bridge attachment (ton), and/or the rate of ADP release.
Strongly bound cross-bridges (e.g., N-ethylmaleimde S1) at
subsaturating [Ca21] increase Vu in skinned muscle ﬁbers
(Swartz and Moss, 2001) and increase the afﬁnity of the thin
ﬁlament for the Tm complex by 104 (Tobacman and Butters,
2000). These data show that consequent to S1 binding to the
thin ﬁlament, a major change in Tm and actin interaction
occurs. Variation of myoﬁbrillar [Ca21] alters not only
isometric force and rate of force redevelopment (ktr), but
also Vu in skinned single muscle ﬁbers (Brenner, 1988;
Julian, 1971). Addition of regulatory proteins to unregulated
actin thin ﬁlaments increases thin ﬁlament in vitro motility
sliding speed, Vo, by as much as 100% (Fraser and Marston,
1995; Bing et al., 1997; Gordon et al., 1998; Homsher et al.,
1996, 2000) and isometric force by 30–70% (Homsher et al.,
2000; Fujita et al., 2002). These results imply that the
interaction of Tm/Tn with the thin ﬁlament modiﬁes both
maximal force and Vo. These effects could be produced by
Tm/Tn modulation of the size of the force and/or
displacement produced by the power stroke, the rate of
ADP release from, and/or the rate of ATP binding to
attached crossbridges.
In the experiments described below we tested the
hypothesis that ADP release may be hastened in the presence
of regulatory proteins by measuring the effects of regulatory
proteins on the rate of thin ﬁlament sliding at saturating
calcium concentrations at various concentrations of ATP and
ADP. Further we measured the effects of regulatory proteins
on Vo at temperatures ranging from 78 to 258C to learn if the
potentiation of Vo by regulatory proteins is temperature
dependent. The results showed that regulatory proteins
reduced the binding afﬁnity of both ATP and ADP for acto-
HMM. However, as the temperature was lowered, the po-
tentiating effects of regulatory proteins on unloaded sliding
speed were lost. Reduction of temperature may reposition
Tm/Tn on the actin surface, or otherwise alter indirect
interactions between myosin and troponin-tropomyosin, thus
preventing the potentiating effects of regulatory proteins on
the unloaded sliding speed.
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Isolation and puriﬁcation of rabbit skeletal myosin or HMM, rabbit skeletal
actin, bovine cardiac troponin (BVCTn), bovine cardiac TnC, and bovine
ventricular tropomyosin (BVCTm) were as previously described (Gordon
et al., 1998; Homsher et al., 1996, 2000).
Motility measurements and analysis
Rhodamine-phalloidin labeled F-actin was prepared as described previously
(Homsher et al., 1996) and used within 2 weeks. Nitrocellulose-coated cover
slips and ﬂow cells were prepared as previously described (Homsher et al.,
1996). An HMM solution (300 mg/ml) was injected into the ﬂow cell. Two
minutes after adding the HMM, the solution was replaced by 50 ml of 0.5
mg/ml bovine serum albumin in assay buffer (25 mMMOPS, 25 mMKCl, 2
mMMgCl2, 2 mM EGTA (pCa 9), 1 mMDTT, pH 7.4). One minute later 50
ml of 20 nM RPh-actin was introduced into the chamber and allowed to
incubate for 2 min. Excess actin was washed off by several 50 ml aliquots of
assay buffer and the solution was replaced by an assay buffer containing 0.5
mM cTm and 0.5 mM cTn and allowed to incubate for 7 min followed by
several washes of assay buffer (containing 100 nM cTm and 100 nM cTn)
and then replaced by a motility solution. This method of reconstituting
regulated thin ﬁlaments already bound to the motility surface prevents thin
ﬁlament bundling which sometimes occurs during incubation of 2 mM actin
with 0.5 mM Tm and 0.5 mM Tn previously used (Homsher et al., 1996; Lin
et al., 1996). It produces thin ﬁlaments that are completely regulated (total
absence of movement at pCa 9), gives a sliding speed and calcium sensitivity
identical to the incubation method, and has been used successfully in
previous work (Homsher et al., 2000; Karibe et al., 2001). The motility
solution contained 120 mM MOPS/KOH (pH 7.4), 2 mM MgCl2, 2 mM
CaEGTA (pCa 5), 0.05–2 mM MgATP, 0–5 mM MgADP, 100 nM cTm,
100 nM cTn, 0.2% methyl cellulose, and 10 mM DTT. Photobleaching
protective agents (Kron et al., 1991), 14 mM glucose, 240 units of glucose
oxidase/ml, and 9 3 103 units of catalase/ml, were also added. The ionic
strength was 91 mM. In experiments in which the temperature was altered
the motility solution contained 25 mM KCl, 25 mMMOPS/KOH (pH 7.4 at
258C), 2 mM CaEGTA, 2 mMMgCl2, 1 mMMgATP, and 10 mM DTT and
100 nM Tm/100 nM Tn along with the photobleaching protective agents.
This solution’s ionic strength was 58 mM. The pKa for MOPS at 258C is 7.2
and the slope of MOPS pKa with respect to temperature is 0.013/8C
(Sankar and Bates, 1978). At 78C, the pH is 7.63 (instead of 7.4 in the
experiments at 258C), and the pCa is 5.2 (instead of the pCa 5.0 at 258C).
The motility chamber was mounted on a temperature-controlled
microscope stage and objective so that temperature could be set at any
value between 78 and 308C. Motility was viewed under ﬂuorescence
illumination through a 1003 objective and the thin ﬁlament movement
recorded using a Dage MSIT camera and Panasonic tape recorder.
Quantiﬁcation of the thin ﬁlament sliding speed was performed using
a Motion Analysis system (Santa Rosa, CA). Data were acquired and
analyzed as previously described (Homsher et al., 1992, 1996) and are
expressed as the mean 6 SE. In these analyses, ﬁlaments not moving at
a uniform sliding speed were rejected. However, the results were
qualitatively the same if, instead, all ﬁlaments were averaged, including
those moving at nonuniform speeds.
RESULTS
To assess the effect of ADP release on the thin ﬁlament
sliding speed, the effect of [ATP] on the rate of thin ﬁlament
sliding at pCa 9 and 5 in the presence and absence of cardiac
regulatory proteins was ﬁrst measured. In control experi-
ments at 258C and pCa 9 in the absence of regulatory pro-
teins, actin ﬁlaments moved over the HMM-coated surface at
the same speed as at pCa 5. Between 80 and 90% of the
ﬁlaments on the surface moved at a uniform speed. However,
at pCa 9, regulated thin ﬁlaments bound to the surface, but
\1% of them moved (and those that did moved at speeds
\0.5 mm s1). This means that the ﬁlaments were well
regulated. Fig. 1 A shows the unregulated thin ﬁlament
sliding speeds as a function of [MgATP] at pCa 5, and Fig.
1 B is the same for regulated thin ﬁlaments. Each point in the
ﬁgures represents the mean6 SE for 100–200 ﬁlaments. The
data show that the results are well ﬁtted by a hyperbolic
function in which the thin ﬁlament sliding speed, Vo, at in-
ﬁnite [MgATP], is 5.36 0.2 mm s1 and is 9.46 0.5 mm s1
(mean6 SE) for regulated thin ﬁlaments. The increased thin
ﬁlament sliding speed at 1 mM [MgATP] in the presence
of regulatory proteins is similar to that previously reported
(Fraser and Marston, 1995; Bing et al., 1997; Gordon et al.,
1998; Homsher et al., 1996, 2000). For unregulated thin
FIGURE 1 The effect of ATP on the sliding speed of thin ﬁlaments in the
absence (A) and (B) presence of troponin and tropomyosin at 258C. The solid
line in each case is a least squares regression of the thin ﬁlament sliding
speed on the [MgATP] for Eq. 1. V ¼ Vo (Km/(Km1[MgATP])) (1) The
results of the ﬁts in A are Vo ¼ 5.3 6 0.2 mm s1 and Km ¼ 118 6 18 mM
(mean 6 SE). The results of the ﬁts in B are Vo ¼ 9.4 6 0.5 mm s1 and
Km ¼ 301 6 47 mM (mean 6 SE).
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ﬁlaments Km for MgATP was 118 6 18 mM while that for
regulated thin ﬁlaments was 301 6 47 mM. (The observed
sliding speeds at 2 mM MgATP for the unregulated thin
ﬁlaments was 89.8% of the Vo (compared to a value of 94.4%
predicted by the regression) and for regulated thin ﬁlaments
was 83.5% of the Vo (compared to a value of 86.9% pre-
dicted by the regression).) These Km values are signiﬁ-
cantly different ( p \ 0.01). The results show that either
MgATP binds more tightly to the unregulated acto-HMM
or MgATP binds with the same afﬁnity, but a forward rate
constant subsequent to binding is slower in unregulated acto-
HMM, resulting in a tighter apparent afﬁnity.
Fig. 2 shows a plot of the thin ﬁlament shortening as
a function of [MgADP] at 2 mM [MgATP]. The data were ﬁt
by the equation:
V ¼ Vo=ððKm=½MgATPÞ3 ð11 ð½MgADP=KiÞÞ1 1Þ;
(1)
where V is the observed thin ﬁlament sliding speed, Vo is the
sliding speed at inﬁnite [MgATP], and Km and Ki are the
Michaelis and inhibition constant, respectively. The data in
Fig. 2 were ﬁtted using the Km values measured in Fig. 1, A
and B. The regressions yield a Vo of 5.86 0.2 and 9.76 0.2
mm s1 (mean 6 SE) for unregulated and regulated thin
ﬁlaments, respectively. These values are not different from
those estimated in Fig. 1. More importantly, MgADP binds
to regulated acto-HMM less strongly (217 6 20 mM) than it
does to unregulated acto-HMM (131 6 17 mM). The
difference in Ki is signiﬁcant at p\ 0.01. Ki is equal to the
ratio of the rate of MgADP release/rate of MgADP binding.
Thus, elevated Ki for regulated thin ﬁlaments may be a result
of a faster dissociation rate of MgADP from acto-HMM-
MgADP. Such behavior could account for the increased
speed of unloaded sliding seen in regulated thin ﬁlaments. If
this is the case, it implies that the binding of the regulatory
proteins to actin modiﬁes actin structure so that its
interaction with MgADP-S1 promotes a more rapid MgADP
release.
Ideally this hypothesis could be tested using stopped
ﬂow measurements of ADP dissociation from acto-HMM-
MgADP. However, at room temperature the rate of MgADP
release from acto-myosin is so fast that it is difﬁcult to
accurately measure it in the absence of regulatory proteins
(Weiss et al., 2001). It could be that the hypothesis can be
tested at a lower temperature. To learn if this was a viable
possibility, we measured the unloaded shortening velocity of
thin ﬁlaments at temperatures ranging from 78 to 258C. The
results are shown in Fig. 3.
Fig. 3 shows that at 258C and 1 mM ATP the unregulated
thin ﬁlaments moved over the surface at 3.8 6 0.5 mm s1
(mean6 SD) while regulated thin ﬁlaments moved at 6.586
1.1 mm s1 (mean 6 SD) and thus reproduce the effects
shown in Figs. 1 and 2. When the temperature was lowered,
the unregulated thin ﬁlament sliding speed declined, but that
of the regulated thin ﬁlaments declined more rapidly with
temperature. At 78C the unregulated thin ﬁlaments moved at
0.44 6 0.03 mm s1 (mean 6 SD) while the regulated thin
ﬁlaments moved at 0.366 0.06 mm s1 (mean6 SD). Such
data would be obtained if at lower temperature there were
reduced calcium binding to the troponin. However, raising
[Ca21] to 1 mM did not alter the thin ﬁlament sliding speed
FIGURE 2 The effect of MgADP on the sliding speed of thin ﬁlaments in
the absence (open circles) and presence ( ﬁlled circles) of (Tm/Tn). The solid
line in each case is the least squares ﬁt of the data to V ¼ Vo/((Km/
[MgATP])(11([MgADP]/Ki)) 1 1), where Ki ¼ kADP off/kADP on. The line
labeled F-Actin is the ﬁt for unregulated actin and that labeled Regulated
Actin is for regulated thin ﬁlaments. The Km MgATP for each condition in
Fig. 1 was used for ﬁtting. The results of the ﬁts for unregulated ﬁlaments
were Vo ¼ 5.8 6 0.0.2 mm s1 and Ki ¼ 131 6 17 mM (mean 6 SE). The
results of the ﬁts for the regulated ﬁlaments was Vo ¼ 9.76 0.2 mm s1 and
Ki ¼ 217 6 20 mM (mean 6 SE).
FIGURE 3 An Arrhenius plot of thin ﬁlament sliding speed for regulated
(open circles) and unregulated ( ﬁlled circles) thin ﬁlaments. The data from
the unregulated ﬁlaments are ﬁtted to with a line having an activation energy
(Ea) of 100 6 2 kJ/mol. Fitting of the data from the regulated thin ﬁlaments
requires two Ea: for temperatures between 178 and 258C, the Ea is 866 2 kJ/
mol while that for temperatures between 78 and 178C is 159 6 19 kJ/mol.
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(data not shown). It might also be that the rise of pH to 7.63
as temperature was lowered modiﬁed the response to reg-
ulatory proteins. However, in control experiments in which
the pH at 78C was set at 7.4, thin ﬁlaments containing the
regulatory proteins moved with a speed which was less
than half that of the unregulated thin ﬁlaments (a result
comparable to that seen at a pH of 7.63). It could also be that
at this temperature the increase in Km for MgATP by
regulatory proteins is so great that Vo is signiﬁcantly less
than its maximal value. The activation energy (Ea) for un-
regulated thin ﬁlament sliding is 100 6 2 kJ/mol and is
close to that earlier reported for unregulated thin ﬁlaments,
98 kJ/mol (Homsher et al., 1992) and the value of 123 6 7
kJ/mol ﬁtted to the data of Anson (1992, Fig. 5) over the
same temperature range as used here. Fitting the data from
the regulated thin ﬁlaments requires two values of Ea. For the
temperature range from 178C and above, the data is well
ﬁtted by an Ea of 86 6 2 kJ/mol while for data from 78 to
178C the Ea is 159 6 19 kJ/mol.
The fraction of thin ﬁlaments sliding at uniform speed at
different temperatures is shown in Fig. 4. It is noteworthy
that the fraction of thin ﬁlaments moving at uniform speed is
greatest for the naked thin ﬁlaments and does not markedly
change with temperature. However, the fraction of uniformly
moving regulated thin ﬁlaments drops markedly with
temperature suggesting that the nature of the interaction
between the thin ﬁlament and the regulatory proteins de-
pends on the ambient temperature. The crossover point
for the sliding speeds is ;128C. The reason for this change
may be related to the fraction of time the regulatory proteins
spend in a position on the actin ﬁlament which allows the
cross-bridges to attach productively.
DISCUSSION
Previous measurements of the Km for MgATP binding to
acto-HMM in motility assays of unregulated thin ﬁlaments
gave values ranging from 70 to 138 mM (Kron and Spudich,
1986; Harada et al., 1987; Homsher et al., 1992; Regnier et al.,
1998; Baker et al., 2002). These values are close to the present
data (118 mM). The inhibitory constant, Ki, for MgADP
binding to unregulated thin ﬁlaments had previously been
measured at 120 6 30 mM (Homsher et al., 1992) and also
agrees with the value measured in this work (1316 17 mM).
Comparable measurements of Vu in skinned single fast rabbit
or rat ﬁbers (contracting at 10–158C) yielded 150–250 mM
for Km and 200 mM for Ki (Chase and Kushmerick, 1995;
Cooke and Pate, 1985; Cooke and Bialek, 1979; Regnier
et al., 1998). While these values are greater than those from in
vitro motility studies, ﬁbers contain regulatory proteins not
present in the unregulated thin ﬁlaments. A more appropriate
comparison would be with the Km and Ki values from
regulated thin ﬁlaments which were 3016 47mMand 2176
20 mM, respectively. These data better ﬁt the skinned muscle
ﬁber data. Although not an explicit objective of these
experiments, an important implication of this data is that
the regulatory proteins increase Vo by 30–80% above that of
unregulated thin ﬁlaments (Lin et al., 1996; Fraser and
Marston, 1995; Homsher et al., 1996, 2000). This is
important because direct comparisons of Vu from intact
muscles and skinnedmuscle ﬁbers are approximately twofold
greater than the Vo measured in vitro motility assays of
unregulated thin ﬁlaments. For example, over the temperature
range 158–358C Vu for intact rat type II muscle ﬁbers is 50%
greater (Ranatunga, 1998) than the comparable unregulated
thin ﬁlament sliding speed (Hook and Larsson, 2000). For
rabbit type II ﬁbers only data from skinned muscle ﬁbers are
available. Vu in these ﬁbers is 4.1 mm s
1/half-sarcomere at
208C and 5.6 mm s1/half-sarcomere at 258C (Pate et al.,
1994). The corresponding unregulated thin ﬁlament in vitro
motility speeds, Vo, are 2.4 mm s
1 at 208C and 4.3 mm s1 at
258C (Homsher et al., 1992). The experiments illustrated in
Fig. 3 give values of 4.0 mm s1 and 6.3 at 208 and 258C,
respectively. These values are also underestimates because
the [MgATP] was only 1 mM in the motility assays,
correction for the effect of a Km of 300 mM, raises these
values to 5.5 and 8.1 mm s1, respectively. Thus, to better
compare Vo from the in vitro motility assays with Vu in intact
and skinned muscle ﬁbers, the motility assays should contain
regulatory proteins bound to the thin ﬁlaments and an
[MgATP] near 5 mM (the physiological concentration used
in most skinned muscle studies).
The increase in Km for MgATP binding to myosin in the
presence of regulated proteins is similar to effects earlier
reported by Resetar and Chalovich (1995) and Kraft et al.
(1992) for MgATP and MgATP-g-S, respectively. In those
reports the Km in the presence of regulatory proteins and
calcium was 6- to10-fold greater than that in the absence of
regulatory proteins. These results show that the interaction of
regulatory proteins with the thin ﬁlament do induce allosteric
effects on kinetic steps involving nucleotide interaction with
myosin.
FIGURE 4 A plot of the fraction of thin ﬁlaments moving as a function of
temperature. The ﬁlled circles are the data for regulated thin ﬁlaments while
the data in open circles are data from unregulated thin ﬁlaments.
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Is it tropomyosin, troponin, or both that control the effect
on thin ﬁlament sliding speed? Earlier studies showed that
the addition of native skeletal or cardiac tropomyosin alone
to thin ﬁlaments (propelled by skeletal myosin) does not
produce an increase in Vo (Homsher et al., 2000; Fraser and
Marston, 1995; VanBuren et al., 2002) although at lower S1
head density, it clearly inhibits thin ﬁlament sliding speed.
(Smooth muscle Tm markedly potentiates sliding speed of
thin ﬁlaments propelled by smooth muscle or limulus
myosin (Umemoto and Sellers, 1990, Wang et al., 1993).
There is smaller increase (;20%) seen using skeletal myosin
when an expressed a-Tm containing an alanine-serine
addition to the amino terminus is used (Bing et al., 1997)).
However, in those studies the concentrations of Tm (100–
200 nM) were probably not great enough to produce
a saturation of Tm binding to the thin ﬁlament (Strand et al.,
2001). Strand et al., (2001) also have produced data
suggesting that at saturating Tm ($2 mM) and a high
density HMM on the motility surface, the speeds of the thin
ﬁlaments were elevated by ;40% above those of un-
regulated actin. Because this effect is crucially dependent on
the HMM density on the surface of the motility slide, we
cannot say with certainty whether or not Tm directly
mediates this response. An increase in thin ﬁlament sliding
speed does occur in the presence of troponin alone or in the
presence of both troponin and tropomyosin. Although
troponin C does not bind signiﬁcantly to actin at concen-
trations used in the in vitro motility studies, both TnI and
TnT do bind to actin (Tobacman and Butters, 2000;
Tobacman et al., 2002). High afﬁnity constants are only
observed when Tm is also present so it is not clear whether
the Tn binding is speciﬁc in the absence of Tm. TnT binds to
actin particularly well in the region of residues 1–153 of
the 284 residue bovine cardiac TnT (Tobacman et al., 2002).
The site of this binding to actin is not certain, but electron
microscopic reconstruction techniques suggest tropomyosin
is positioned onto the same surface of actin to which S1
binds (Tobacman et al., 2002). Cardiac TnI binds to the same
surface on actin via residues (141–153) near cysteine-42 of
actin and via residues 183–203 to unidentiﬁed residues on
actin (Van Eyk et al., 1997; Lehman et al., 2001).
What is the mechanism by which regulatory proteins exert
these effects? We argue that this occurs because regulatory
proteins increase the rate of ADP release. This conclusion
seems inconsistent with the results of Rosenfeld and Taylor
(1987) who found that the rate of Mg-e-ADP release from
both unregulated and regulated acto-S1 was about the same
(450–600 s1). This rate is much less than that of MgADP
(Weiss et al., 2001; Siemankovski et al., 1985). Further in
work in our group (Pavlov et al., 2003) we ﬁnd that Vo in 1–2
mM e-ATP at 258C is only ;30% (1.3 mm s1) of that seen
in ATP and Vo is the same in the presence and absence of
regulatory proteins. Therefore, the features of acto-myosin
interaction that produce the effects seen in MgATP are
ineffective in Mg-e-ATP.
Because the effect of regulatory proteins on thin ﬁlament
sliding involves changes in the binding of ATP and ADP to
the acto-S1, it is likely that regulatory proteins promote
changes in the actin sites that bind to S1 and thus inﬂuence
the structure of the S1 molecule itself. This is an idea
previously called allosteric or kinetic regulation of contrac-
tion (for an excellent analysis of this idea see Chalovich,
1992). In its original form the kinetic mechanism of
regulation hypothesized that regulatory proteins accelerate
a weak to strong crossbridge transition associated with
product (Pi and ADP) release steps. However, measurement
of the effects of Pi on the isometric tension transients implied
that neither the force generating step nor the release of Pi
were regulated by calcium (Millar and Homsher, 1990). It
was instead suggested that calcium controlled a weak to
strong crossbridge transition preceding both the force
generation and Pi release steps. Subsequently, data was
obtained showing that thin ﬁlament sliding speed and/or
unloaded shortening velocity were increased by point
mutations of regulatory proteins (Sweeney et al., 1998; Lin
et al., 1996; Bing et al., 1997; Homsher et al., 2000). These
data were most simply explained by assuming that the rate of
MgADP release from the acto-S1-MgADP complex was
accelerated by the regulatory proteins. This notion is re-
enforced by the facts that the presence of S1 increases
the afﬁnity of the regulatory proteins for actin by ;104
(Tobacman and Butters, 2000) and the presence of the
regulatory proteins increases S1-actin afﬁnity by four- to
sevenfold (Geeves and Halsall, 2002; Williams and Greene,
1983; Tobacman and Butters, 2000). Thus, there is abundant
evidence for allosteric regulation of nucleotide and S1
binding to actin by regulatory proteins.
How might regulatory thin ﬁlaments modulate kinetic
steps associated with the cross-bridge cycle? Evidence from
both biochemical (McKillop and Geeves, 1993) and struc-
tural (Xu et al., 1999) studies indicates that Tm exists in three
different positions on the thin ﬁlament: the ‘‘blocked’’ state
(near the external edge of the ﬁlament, blocking weak and
strong myosin binding sites in the absence of calcium); the
closed state (nearer the groove between the two actin strands,
partially weak and strong binding sites in the presence of
calcium); and the ‘‘open’’ state (nearer still to the groove
between the two actin strands fully exposing myosin bind-
ing sites when the cross-bridges are attached to the actin
ﬁlament). The activation of cross-bridge attachment to actin
thus depends on the positioning of the regulatory proteins
and they are believed to occupy these positions dependent on
the equilibrium constants between the different states. The
important point is that the changing position of the reg-
ulatory proteins implies that different actin amino acid
residues interact with the thin regulatory proteins. These
interactions could produce structural changes in actin, which
could inﬂuence the interaction of actin-myosin and ADP. An
alternative possibility is that the regulatory proteins, by
virtue of their positioning on the thin ﬁlament, may also
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interact with the regions of S1 adjacent to the actin-binding
surface. There is little known about the speciﬁc actin, tro-
pomyosin, or troponin interaction sites because the structure
of the actin-troponin/tropomyosin-S1 form is not known. In
any case, the present results establish that the regulatory
proteins do modulate actomyosin interaction with its nu-
cleotide, thereby altering ﬁlament sliding over a myosin-
coated surface in vitro. It is only a modest extrapolation to
predict corresponding effects of the regulatory proteins on
the mechanical behavior of intact muscle.
The failure of regulatory proteins to potentiate unloaded
sliding speed at temperatures lower than ;108C was an
unexpected ﬁnding. At least two explanations are possible.
One could be that the interaction of Tm/Tn with actin that
may accelerate the rate of MgADP release from the acto-
myosin S1-ADP complex might be altered. Using the idea
that the activation of the thin ﬁlament depends on the
positioning of Tm/Tn on the thin ﬁlament, it could be that
at temperatures above 108C the equilibrium between the
‘‘open’’ and ‘‘closed’’ states is shifted toward the ‘‘closed
state’’ while at higher temperatures the equilibrium shifts
toward the ‘‘open’’ state. This implies that the speciﬁc
interactions between Tm/Tn and actin and/or myosin are
different in the two different states. If the free energy
change for the transition from the ‘‘closed’’ to the ‘‘open’’
position is relatively small (Tobacman and Butters, 2000;
Tobacman et al., 2002), then as the temperature is reduced,
less time will be spent in the open position so that the
effective number of cross-bridges pulling on thin ﬁlaments
will be reduced. On the other hand, this interpretation does
not exclude the possibility that at low temperatures myosin
and the regulatory proteins affect each other via alterations
in actin structure. In fact, the afﬁnity of tropomyosin for
actin at 108C is increased by at least an order of magnitude
by addition of myosin S1 and is too tight to readily
measure (M. Heller and L. Tobacman, data not shown).
Finally, it is well known that as temperature is raised, the
force of isometrically contracting muscle ﬁbers increases
(Ford et al., 1977). It may be that as temperature rises Tm/
Tn complex shifts toward the ‘‘open’’ position. An
alternative explanation for the temperature dependence of
the regulatory protein effects on unloaded sliding speed is
that the rate limiting step in the ATPase mechanism
changes with temperature so that the effects of the
regulatory protein are no longer affecting the step that
controls sliding speed.
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